The Claim

The only human pharmacokinetic data for BPC-157 are derived from a two-subject pilot study with intravenous administration, which confirms rapid clearance directionally but lacks statistical power to characterize bioavailability, inter-individual variability, or absorption kinetics for any route other than intravenous.

Source: BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
1score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Description
1 study reviewed
In plain English

Human data on how BPC-157 moves through the body comes from a study with only two people who received the substance intravenously. This data shows the substance clears quickly, but it cannot determine how much is absorbed, how much varies between people, or how it behaves through other routes of administration.

See the scientific wording

The only human pharmacokinetic data for BPC-157 come from a two-subject pilot study involving intravenous administration, which provides directional confirmation of rapid clearance but is statistically insufficient to characterize bioavailability, inter-individual variability, or absorption kinetics for any route other than IV.

Why this might work

BPC-157 survives stomach acid because of its unique shape, allowing it to act directly on the gut lining to start healing. It turns on genes that make repair proteins, boosts blood vessel growth, and reduces inflammation by increasing nitric oxide and blocking harmful signals. These actions help fix damaged tissue without needing the peptide to enter the bloodstream.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers

    Only two people have ever had their blood tested after taking BPC-157, and both got it through an IV. We don’t have enough data to know how well it works if taken by mouth or injection under the skin.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.